Aardvark Therapeutics, Inc 10-K for FY2025
Aardvark Therapeutics, Inc. (AARD)
10-K
2026-03-23
For: 2025-12-31
View Original
Added on
April 07, 2026
About this 10-K
Aardvark Therapeutics, Inc filed this 10-K on March 23, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- Net loss
- $57.59M
- compared with a net loss of $20.59M a year earlier
- Diluted EPS
- -$2.93
- compared with -$5.15 a year earlier